Literature DB >> 18580612

Clinical features and etiology of pneumonia in acid-fast bacillus sputum smear-negative HIV-infected patients hospitalized in Asia and Africa.

Muriel Vray1, Yves Germani, Sarin Chan, Nguyen H Duc, Borann Sar, Fatoumata D Sarr, Raymond Bercion, Lila Rahalison, Maryvonne Maynard, Pierre L'Her, Loic Chartier, Charles Mayaud.   

Abstract

OBJECTIVES: To determine the main causes of acid-fast bacillus sputum smear-negative pneumonia in Asian and African HIV-infected patients DESIGN AND
SETTING: A prospective multicenter study (ANRS 1260) of consecutive hospitalized patients in tertiary hospitals in Phnom Penh, Ho Chi Minh City, Bangui and Dakar. INTERVENTION: Use of the same clinical, radiological and biological methods at the four sites; regular quality controls of participating laboratories; final review of medical records by experts. Similar criteria used to establish diagnoses.
RESULTS: In all 462 patients were enrolled, 291 in Asia and 171 in Africa. The median CD4 cell count was 25 cells/microl. Radiological opacities were diffuse in 42% of patients and localized in 45%. Fiberoptic bronchoscopy was performed in 354 patients, at similar rates in the four sites. A definite and/or probable diagnosis was obtained in 375 patients (81%). Pneumocystis jiroveci pneumonia, bacterial pneumonia, AFB sputum smear-negative tuberculosis and other infections (fungi, parasites, atypical mycobacteria) were diagnosed in respectively 47, 30, 17 and 12% of Asian patients and 3, 48, 26 and 5% of African patients.
CONCLUSION: In South-east Asia, acid-fast bacillus smear-negative pneumonia is caused by a wide variety of pathogens. When possible, fiberoptic bronchoscopy must be performed rapidly if clinical data are not highly suggestive of bacterial pneumonia, Pneumocystis jiroveci pneumonia or tuberculosis. In contrast, in Africa, bacterial pneumonia and tuberculosis are responsible for the large majority of cases. Fiberoptic bronchoscopy should be restricted to patients with clinical and/or radiological findings not suggestive of bacterial pneumonia or tuberculosis, antibiotic failure, and three consecutive negative sputum smears.

Entities:  

Mesh:

Year:  2008        PMID: 18580612     DOI: 10.1097/QAD.0b013e3282fdf8bf

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  9 in total

1.  Evidence for high prevalence of Pneumocystis jirovecii exposure among Cameroonians.

Authors:  Stephenson W Nkinin; Kieran R Daly; Peter D Walzer; Edward S Ndzi; Tazoacha Asonganyi; Nieves Respaldiza; Francisco J Medrano; Edna S Kaneshiro
Journal:  Acta Trop       Date:  2009-08-07       Impact factor: 3.112

2.  The prevalence of laboratory-confirmed Pneumocystis jirovecii in HIV-infected adults in Africa: A systematic review and meta-analysis.

Authors:  Nicola K Wills; David S Lawrence; Elizabeth Botsile; Mark W Tenforde; Joseph N Jarvis
Journal:  Med Mycol       Date:  2021-07-14       Impact factor: 4.076

3.  Etiology and Incidence of viral and bacterial acute respiratory illness among older children and adults in rural western Kenya, 2007-2010.

Authors:  Daniel R Feikin; M Kariuki Njenga; Godfrey Bigogo; Barrack Aura; George Aol; Allan Audi; Geoffrey Jagero; Peter Ochieng Muluare; Stella Gikunju; Leonard Nderitu; Amanda Balish; Jonas Winchell; Eileen Schneider; Dean Erdman; M Steven Oberste; Mark A Katz; Robert F Breiman
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

4.  Acute lower respiratory infections in ≥ 5 year -old hospitalized patients in Cambodia, a low-income tropical country: clinical characteristics and pathogenic etiology.

Authors:  Sirenda Vong; Bertrand Guillard; Laurence Borand; Blandine Rammaert; Sophie Goyet; Vantha Te; Patrich Lorn Try; Sopheak Hem; Sareth Rith; Sowath Ly; Philippe Cavailler; Charles Mayaud; Philippe Buchy
Journal:  BMC Infect Dis       Date:  2013-02-22       Impact factor: 3.090

Review 5.  Pneumocystis jirovecii pneumonia in developing countries.

Authors:  Y de Armas Rodríguez; G Wissmann; A L Müller; M A Pederiva; M C Brum; R L Brackmann; V Capó de Paz; E J Calderón
Journal:  Parasite       Date:  2011-08       Impact factor: 3.000

6.  Low prevalence of Pneumocystis pneumonia (PCP) but high prevalence of pneumocystis dihydropteroate synthase (dhps) gene mutations in HIV-infected persons in Uganda.

Authors:  Steve M Taylor; Steven R Meshnick; William Worodria; Alfred Andama; Adithya Cattamanchi; J Lucian Davis; Samuel D Yoo; Patrick Byanyima; Sylvia Kaswabuli; Carol D Goodman; Laurence Huang
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

7.  Factors associated with negative direct sputum examination in Asian and African HIV-infected patients with tuberculosis (ANRS 1260).

Authors:  Loïc Chartier; Chanthy Leng; Jean-Marie Sire; Odile Le Minor; Manil Saman; Raymond Bercion; Lila Rahalison; Arnaud Fontanet; Yves Germany; Pierre L'her; Charles Mayaud; Muriel Vray
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

8.  Etiology and Risk Factors for Mortality in an Adult Community-acquired Pneumonia Cohort in Malawi.

Authors:  Stephen J Aston; Antonia Ho; Hannah Jary; Jacqueline Huwa; Tamara Mitchell; Sarah Ibitoye; Simon Greenwood; Elizabeth Joekes; Arthur Daire; Jane Mallewa; Dean Everett; Mulinda Nyirenda; Brian Faragher; Henry C Mwandumba; Robert S Heyderman; Stephen B Gordon
Journal:  Am J Respir Crit Care Med       Date:  2019-08-01       Impact factor: 21.405

9.  Integrating sepsis management recommendations into clinical care guidelines for district hospitals in resource-limited settings: the necessity to augment new guidelines with future research.

Authors:  Shevin T Jacob; Matthew Lim; Patrick Banura; Satish Bhagwanjee; Julian Bion; Allen C Cheng; Hillary Cohen; Jeremy Farrar; Sandy Gove; Philip Hopewell; Christopher C Moore; Cathy Roth; T Eoin West
Journal:  BMC Med       Date:  2013-04-18       Impact factor: 8.775

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.